By Malcolm Stacey | Wednesday 27 January 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Chasers. The share price of Avacta (AVCT) shares is holding up rather well, considering that vaccines will soon render the virus far less common. Perhaps the world expects testing to be needed until the virus disappears altogether. And we all know that’s unlikely. So, if Avacta shares continue to do well, perhaps we could consider another company which also has some news on the testing front…